---

Intranasal insulin therapy in the treatment of alzheimer’s disease – A narrative review

---

Original Article

Author Details : Asmita Nene*, Jenifer Rodriguez Santoni

Volume : 9, Issue : 1, Year : 2023

Article Page : 25-32

https://doi.org/10.18231/j.ijashnb.2023.006

Suggest article by email

Get Permission

---

Abstract

The administration of intranasal insulin improves symptoms related to Alzheimer’s disease. The research was conducted through a hypothesis-based review, such as, PubMed, DynaMed, and EBSCOhost. The articles published between 2011 and 2020 were included. The studies included randomized controlled trials and cohort studies. The study populations included participants associated with cognitive-related conditions. The group of humans and animal models were also considered. All ten articles showed how the administration of intranasal insulin can improve the symptoms related to Alzheimer’s disease. However, these findings varied on the level of dose used, the duration of the treatment and the type of insulin formulations used. Future studies can consider to provide a more homogenous group of study population, cognitive-related activities to observe, and duration of the administration in order to provide a more credible result.

Keywords: Intranasal insulin, Insulin signaling, Alzheimer's disease, Dementia, Cognitive impairment

How to cite : Nene A, Santoni J R, Intranasal insulin therapy in the treatment of alzheimer’s disease – A narrative review. IP Indian J Anat Surg Head Neck Brain 2023;9(1):25-32

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.